bitterlyclingin
Silver Member
- Aug 4, 2011
- 3,122
- 425
- 98
(Fancy that! A no bid contract for a political supporter to develop a vaccine for a disease that has supposedly been eradicated from the human population for the last thirty three years or so. Maybe its Janet N's innate fear that one of those returning Iraqi war veterans might have hatched up a new batch to bring back with him and unleash on a crowd of unsuspecting Democrats frolicking on a night out on Fire Island. Couldn't let that happen, could she? Definitely the wrong crowd of people, lots of squeaky wheels in that bunch, and they already have enough diseases to worry about anyway.)
"The Ex-SEIU Boss, Donor Dollars, No-Bid Contracts & Testing Anthrax Vaccines on Kids
Posted by LaborUnionReport (Diary)
Sunday, November 13th at 8:00AM EST
According to the Los Angeles Times, with the exception of existing in locked freezers in Russia and U.S. labs, the smallpox virus was eradicated in 1978. Yet, in a no-bid contract, the Obama administration has given $443 million of American taxpayers money for a experimental smallpox drug to a bio-defense company, Siga, controlled by billionaire Democrat-donor Ron Perleman and whose board ex-SEIU boss Andy Stern sits on.
According to the Times:
When Siga complained that contracting specialists at the Department of Health and Human Services were resisting the companys financial demands, senior officials replaced the governments lead negotiator for the deal, interviews and documents show.
When Siga was in danger of losing its grip on the contract a year ago, the officials blocked other firms from competing.
Siga was awarded the final contract in May through a sole-source procurement in which it was the only company asked to submit a proposal. The contract calls for Siga to deliver 1.7 million doses of the drug for the nations biodefense stockpile. The price of approximately $255 per dose is well above what the governments specialists had earlier said was reasonable, according to internal documents and interviews.
Sigas questionable government deal may eventually mean $2.8 billion in revenues for the companythought Sigas profits would have to be split with its former partner in a failed merger, PharmAthene.
merger, PharmAthene.
In September, after years of litigation following a failed merger, a Delaware court ruled that PharmAthene was entitled to 50% of Sigas profits from its ST-246 smallpox vaccines.
While the Times notes that there is no credible evidence that the threat of a smallpox outbreak is imminent and that the U.S. already owns enough vaccine to treat the entire population, the Obama administrations ties to Siga become even more questionable, considering the recent recommendation to start experimenting with an Anthrax vaccine on Americas children.
A key panel of government advisers Friday recommended that the federal government sponsor a controversial study to test the anthrax vaccine in children to see whether the inoculation would protect young Americans against a bioterrorist attack.
The National Biodefense Science Board (NBSB), which advises the federal government on issues related to bioterrorism, voted 12-1 to recommend that the Health and Human Services Department move forward with a study aimed at determining whether the vaccine is safe and effective in children and identifying the best dose. Patricia Quinlisk of the Iowa Department of Public Health, who chairs the panel, was the only dissenter.
[snip]
Nicole Lurie, the assistant HHS secretary for preparedness and response who requested the panels review, said officials would consider the panels recommendation, but she did not give a time-frame for a decision on whether to conduct the study. [Emphasis added.]"
The Ex-SEIU Boss, Donor Dollars, No-Bid Contracts & Testing Anthrax Vaccines on Kids | RedState
"The Ex-SEIU Boss, Donor Dollars, No-Bid Contracts & Testing Anthrax Vaccines on Kids
Posted by LaborUnionReport (Diary)
Sunday, November 13th at 8:00AM EST
According to the Los Angeles Times, with the exception of existing in locked freezers in Russia and U.S. labs, the smallpox virus was eradicated in 1978. Yet, in a no-bid contract, the Obama administration has given $443 million of American taxpayers money for a experimental smallpox drug to a bio-defense company, Siga, controlled by billionaire Democrat-donor Ron Perleman and whose board ex-SEIU boss Andy Stern sits on.
According to the Times:
When Siga complained that contracting specialists at the Department of Health and Human Services were resisting the companys financial demands, senior officials replaced the governments lead negotiator for the deal, interviews and documents show.
When Siga was in danger of losing its grip on the contract a year ago, the officials blocked other firms from competing.
Siga was awarded the final contract in May through a sole-source procurement in which it was the only company asked to submit a proposal. The contract calls for Siga to deliver 1.7 million doses of the drug for the nations biodefense stockpile. The price of approximately $255 per dose is well above what the governments specialists had earlier said was reasonable, according to internal documents and interviews.
Sigas questionable government deal may eventually mean $2.8 billion in revenues for the companythought Sigas profits would have to be split with its former partner in a failed merger, PharmAthene.
merger, PharmAthene.
In September, after years of litigation following a failed merger, a Delaware court ruled that PharmAthene was entitled to 50% of Sigas profits from its ST-246 smallpox vaccines.
While the Times notes that there is no credible evidence that the threat of a smallpox outbreak is imminent and that the U.S. already owns enough vaccine to treat the entire population, the Obama administrations ties to Siga become even more questionable, considering the recent recommendation to start experimenting with an Anthrax vaccine on Americas children.
A key panel of government advisers Friday recommended that the federal government sponsor a controversial study to test the anthrax vaccine in children to see whether the inoculation would protect young Americans against a bioterrorist attack.
The National Biodefense Science Board (NBSB), which advises the federal government on issues related to bioterrorism, voted 12-1 to recommend that the Health and Human Services Department move forward with a study aimed at determining whether the vaccine is safe and effective in children and identifying the best dose. Patricia Quinlisk of the Iowa Department of Public Health, who chairs the panel, was the only dissenter.
[snip]
Nicole Lurie, the assistant HHS secretary for preparedness and response who requested the panels review, said officials would consider the panels recommendation, but she did not give a time-frame for a decision on whether to conduct the study. [Emphasis added.]"
The Ex-SEIU Boss, Donor Dollars, No-Bid Contracts & Testing Anthrax Vaccines on Kids | RedState
